Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 3 | Molecular Cancer

Figure 3

From: Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents in non-small cell lung cancer cells

Figure 3

Synergistic activity of ReoT3D and paclitaxel combination in NCI-H460 cells as demonstrated by (a) the leftward shift of the dose response curve (error bars: SD), (b) isobologram analysis (shown are for the ED50 doses), and (c) fractional effect-combination index (CI) plot generated by CalcuSyn (Biosoft, Ferguson, MO). The data shown are representative of 3 separate experiments.

Back to article page